Related Experiment Video
Updated: Jun 27, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Reaction of bone marrow hematopoiesis to the toxic effect of paclitaxel
A A Churin1, V E Gol'dberg, G V Karpova
1Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences. toxicol@sibmail.com
Abstract:
Intraperitoneal injection of paclitaxel (Mitotax) in a single dose of 40 mg/kg was followed by an increase in the number of mitotic granulocytic and erythroid cells, hypoplasia, and pancytopenia of the bone marrow in CBA/CaLac mice. The test preparation decreased the number of hematopoietic precursor cells for erythropoiesis and granulocytopoiesis, but increased the count of polyploid cells and incidence of structural and genomic abnormalities in bone marrow cells. These changes were reversible.
Related Concept Videos
Drugs that Stabilize Microtubules
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Regulation of Hematopoietic Stem Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
